Acro Biomedical Co., Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Acro Biomedical Co., Ltd.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 45% to $658,500. Profit margin reached -2410%. Total operating expenses were $16,010,237.

Profit Margin

Acro Biomedical Co., Ltd. (OTC:ACBM): Profit margin
2015 0 -47.49K
2016 0 -43.42K
2017 510K -2.24K -0.44%
2018 8.01M 419.66K 5.24%
2019 193.53K -371.60K -192.01%
2020 687.96K -117.45K -17.07%
2021 1.19M -7.70M -643.18%
2022 658.5K -15.87M -2410.24%

ACBM Income Statement (2015 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
658.5K1.19M687.96K193.53K8.01M510K00
Cost of revenue
518K938K528.56K181.44K7.18M459K00
Gross profit
140.5K259.5K159.40K12.09K833.4K51K00
Operating exp.
Research and development
10.08M5.28M000000
Selling and marketing
00000000
Total operating expenses
16.01M7.95M289.86K434.84K317.85K53.24K43.42K47.49K
Operating income
-15.86M-7.69M-130.46K-422.75K515.55K-2.24K-43.42K-47.49K
Other income (expenses), net
-1.70K-4.25K-5.08K-1.98K-3.66K000
Income before tax
-15.87M-7.69M-135.54K-424.73K511.88K-2.24K-43.42K-47.49K
Income tax expense
-15.86M4.25K-18.09K-53.13K92.22K-2.24K0-47.49K
Net income
-15.87M-7.70M-117.45K-371.60K419.66K-2.24K-43.42K-47.49K
Earnings per share
Basic EPS
-0.26-0.14-0.00-0.000.000-0.00-0.00
Diluted EPS
-0.26-0.14-0.00-0.000.000-0.00-0.00
Data sourceData sourceData sourceData sourceData sourceData source